Timeline of Lilly’s outsourcing

By Nick Taylor

- Last updated on GMT

Timeline of Lilly’s outsourcing
Eli Lilly has taken an expansive approach to outsourcing, adding an agreement with Thermo Fisher to its raft of deals, and this strategy is visualised in an interactive timeline from Outsourcing-Pharma.

Since committing to an outsourcing strategy in December 2007 the big pharma has inked a number of deals spanning clinical trials, active pharmaceutical ingredients (API) and drug discovery.

This strategy, which is among the most expansive in the industry, is visualised below. Move the mouse over an area to show headlines and click on the text bubbles to bring up further information and a link to the complete article.

Related news

Show more

Related products

show more

VDS groß

Meet the challenges of complex injectables

Vetter Pharma International GmbH | 07-Nov-2017 | Technical / White Paper

In the time it takes from the exciting discovery phase to the rigorous demands of a commercial launch, unexpected scientific and technical challenges can...

lyo_vials

Process Development for Lyophilized Products

Baxter BioPharma Solutions | 30-Oct-2017 | Application Note

Baxter approaches formulation and process development with the intention of identifying the failure points for the product. Knowing where the product fails...

Ocopeptides

Advancing therapeutics for myeloma

Recipharm AB | 04-Sep-2017 | Case Study

Multiple myeloma is the second most common blood cancer in the world and despite survival rates increasing over the last decade, there remains a requirement...

Related suppliers